Switch to:

CRISPR Therapeutics AG Other Financing

: $19.4 Mil (TTM As of Jun. 2020)
View and export this data going back to 2016. Start your Free Trial

CRISPR Therapeutics AG's Other Financing for the three months ended in Jun. 2020 was $6.5 Mil.

CRISPR Therapeutics AG's Other Financing for the trailing twelve months (TTM) ended in Jun. 2020 was $19.4 Mil.


CRISPR Therapeutics AG Other Financing Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Other Financing Premium Member Only -0.13 -1.78 0.00 8.94 15.96

CRISPR Therapeutics AG Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Other Financing Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.25 1.96 10.92 0.00 6.48

CRISPR Therapeutics AG Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2020 was 1.963 (Sep. 2019 ) + 10.915 (Dec. 2019 ) + 0 (Mar. 2020 ) + 6.484 (Jun. 2020 ) = $19.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


CRISPR Therapeutics AG Other Financing Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)